Table 3 Postoperative Outcomes for Rhizotomy, Balloon Ablation, and MVD
| Â | BA | MVD | Rhizotomy | Combined |
|---|---|---|---|---|
Hospital Length of Stay (Days) | 2.6 ± 0.4 | 5.7 ± 0.6 * | 4.3 ± 0.2 | 5.0 ± 0.3 |
Without Complications (Days) | 0.5 ± 0.1 | 4.6 ± 0.6 | 3.3 ± 0.3 |  |
Length of Follow-up (Months) | 21.8 ± 3.2 | 33.4 ± 7.1 | 21.0 ± 4.9 | 26.5 ± 42 |
Incidence of Immediate Improvement in Symptoms | 56/78 (72%) | 31/34 (91%) * | 35/41 (85%) * | 66/75 (88%) |
Improvement of Symptoms with Bradycardia | 75% | 87% | 80% | 84% |
Incidence of Total Cure | 31/78 (40%) ** | 23/34 (68%) | 22/41 (54%) ** | 45/75 (60%) |
Incidence of No Change in Symptoms | 21/78 (27%) | 2/34 (6%) * | 6/41 (15%) * | 8/75 (11%)* |
Incidence of Requirement for Post-Op Medications to Treat TN | 45/77 (58%) ** | 8/34 (24%) | 21/41 (51%) | 29/75 (39%) |
Incidence of Post-operative Relapse | 8/83 (10%) | 4/37 (11%) | 4/43 (9%) | 8/75 (10%) |
Incidence of need to have re- operation | 22/78 (28%) | 3/34 (9%) * | 2/42 (5%) * | 5/76 (7%) |
Time Until Relapse (Months) | 12.1 ± 3.1 | 10.6 ± 8.5 | 6.3 ± 1.2 | 8.4 ± 4.1 |
Number of Patients Lost to Follow-up (%) | 7/82 (9%) | 5/37 (14%) | 4/43 (9%) | 9/80 (11%) |